×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)

SK-Hep-1 (人肝癌细胞) (STR鉴定正确)

货号:CL-0212

规格:1×10⁶cells/T25培养瓶

价格: ¥2000

生长培养基:MEM(含NEAA)10% FBS1% P/S

数量: - +

  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
  • SK-Hep-1 (人肝癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

SK-Hep-1 (人肝癌细胞) (STR鉴定正确) ¥2000
SK-Hep-1细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥2350¥2450

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 SK-Hep-1 (人肝癌细胞) (STR鉴定正确)
别称 SK-Hep-1; SK HEP-1; SK HEP 01; SK-Hep1; Sk-Hep1; SK Hep1; SKHEP-1; SKHEP1; SKHep1; SK_HEP1
种属
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:2-1:4
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 SK-HEP-1细胞已被鉴定为内皮来源。SK-HEP-1细胞来源于52岁男性,染色体在亚三倍体范围内。在裸鼠中,SK-HEP-1细胞能形成与肝癌相一致的大细胞癌。
年龄(性别) 男性;52岁
组织来源 腺癌,肝,腹水
细胞类型 肿瘤细胞
肿瘤类型 肝胆癌细胞
生物安全等级 BSL-1
倍增时间 ~30 hours
致瘤性 Yes, in nude mice; forms large cell carcinoma consistent with hepatoma.
保藏机构 ATCC; HTB-52 DSMZ; ACC-141 ECACC; 91091816
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 11,12
    D2S1338 20,23
    D3S1358 16
    D5S818 10,13
    D7S820 8,11
    D8S1179 13,14
    D13S317 8,12
    D16S539 12
    D18S51 13,15
    D19S433 12,15.2
    D21S11 29,31
    FGA 17
    PentaD 13,14
    PentaE 13,21
    TH01 7,9
    TPOX 9
    vWA 14,17
    D6S1043 11
    D12S391 18,19
    D2S441 12.3,14
  • STR鉴定图
参考文献
文献列表
  • SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma(2022/11/15)

    作者:Hu, Qingqing, Liu, Qiuhong, Zhao, Yalei, Zhang, Lingjian, Li, Lanjuan

    期刊:Biomarker Research

    DOI:10.1186/s40364-022-00422-z

    影响因子 :11.100

    引用产品:CL-0102 CL-0212

  • Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells(2019/05/03)

    作者:Le Wang, Yuemin Feng, Xiaoyu Xie

    期刊:EBioMedicine

    DOI:10.1016/j.ebiom.2019.04.050

    影响因子 :11.100

    引用产品:CL-0212

  • Nanoparticle-Stabilized Emulsion Bioink for Digital Light Processing Based 3D Bioprinting of Porous Tissue Constructs(2022/03/04)

    作者:Jie Tao, Shunyao Zhu, Nazi Zhou

    期刊:Advanced Healthcare Materials

    DOI:10.1002/adhm.202102810

    影响因子 :11.092

    引用产品:CL-0044 CL-0171 CL-0212

  • ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression(2022/08/01)

    作者:Yu You, Diguang Wen, Lu Zeng

    期刊:International Journal of Biological Sciences

    DOI:10.7150/ijbs.70149

    影响因子 :9.200

    引用产品:CL-0102 CL-0103 CL-0120 CL-0212 CL-0233 CL-0341

  • ncRNAs-mediated high expression of TICRR promotes tumor cell proliferation and migration and is correlated with poor prognosis and tumor immune infiltration of hepatocellular carcinoma(2022/09/19)

    作者:Kejie He, Yangfan Zhang, Laiying Liang

    期刊:Molecular Therapy-Nucleic Acids

    DOI:10.1016/j.omtn.2022.09.007

    影响因子 :8.800

    引用产品:CL-0120 CL-0212

  • S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway(2022/08/16)

    作者:Yan Sun, Huan Zhang, Junpeng Meng

    期刊:Cell Reports

    DOI:10.1016/j.celrep.2022.111194

    影响因子 :8.800

    引用产品:CL-0005 CL-0102 CL-0103 CL-0120 CL-0212

  • Comprehensive analysis of ubiquitin‐specific protease 1 reveals its importance in hepatocellular carcinoma(2020/09/19)

    作者:Yalei Zhao, Chen Xue, Zhongyang Xie

    期刊:Cell Proliferation

    DOI:10.1111/cpr.12908

    影响因子 :8.500

    引用产品:CL-0212

  • LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway(2021/11/27)

    作者:Ying Xing,Yang Liu,Zhong Qi

    期刊:Cellular & Molecular Biology Letters

    DOI:10.1186/s11658-021-00295-4

    影响因子 :8.300

    引用产品:CL-0102 CL-0120 CL-0212

  • 5′-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with eukaryotic initiation factor 4A-I(2023/03/28)

    作者:Chengdong Wu, Dekai Liu, Lufei Zhang

    期刊:Frontiers of Medicine

    DOI:10.1007/s11684-022-0966-6

    影响因子 :8.100

    引用产品:CL-0102 CL-0120 CL-0139 CL-0212

  • Identification and analysis of C17orf53 as a prognostic signature for hepatocellular carcinoma(2022/11/28)

    作者:Yalei Zhao, Lingjian Zhang, Qingqing Hu, Danhua Zhu, Zhongyang Xie

    期刊:COMPUTERS IN BIOLOGY AND MEDICINE

    DOI:10.1016/j.compbiomed.2022.106348

    影响因子 :7.700

    引用产品:CL-0212

  • Dual role of PID1 in regulating apoptosis induced by distinct anticancer-agents through AKT/Raf-1-dependent pathway in hepatocellular carcinoma(2023/04/28)

    作者:Jian Yang, Senlin Li, Jialuo He

    期刊:Cell Death Discovery

    DOI:10.1038/s41420-023-01405-1

    影响因子 :7.000

    引用产品:CL-0102 CL-0103 CL-0212

  • VEZF1, destabilized by STUB1, affects cellular growth and metastasis of hepatocellular carcinoma by transcriptionally regulating PAQR4(2022/10/14)

    作者:Xiaobao Shi, Pengfei Zhao, Gang Zhao

    期刊:Cancer Gene Therapy

    DOI:10.1038/s41417-022-00540-8

    影响因子 :6.400

    引用产品:CL-0102 CL-0120 CL-0212 CL-0415

  • CRHBP is degraded via autophagy and exerts anti-hepatocellular carcinoma effects by reducing cyclin B2 expression and dissociating cyclin B2-CDK1 complex(2022/01/27)

    作者:Zhiwei Wang, Mingxing Li, Yuanfeng Liu

    期刊:Cancer Gene Therapy

    DOI:10.1038/s41417-021-00423-4

    影响因子 :5.854

    引用产品:CL-0120 CL-0139 CL-0212

  • Bufalin enhances the killing efficacy of NK cells against hepatocellular carcinoma by inhibiting MICA shedding(2021/10/19)

    作者:Rao Fu, Fangjing Yu, Weiqi Wu

    期刊:International Immunopharmacology

    DOI:10.1016/j.intimp.2021.108195

    影响因子 :5.714

    引用产品:CL-0103 CL-0212 CL-0533 CM-0533

  • Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress(2021/10/05)

    作者:Yang Tai, Chong Zhao, Linhao Zhang

    期刊:Journal Of Cellular And Molecular Medicine

    DOI:10.1111/jcmm.16968

    影响因子 :5.300

    引用产品:CL-0212

  • PI3K δ inhibitor PI-3065 induces apoptosis in hepatocellular carcinoma cells by targeting survivin(2023/01/06)

    作者:Yuze Wei, Weiwei Ke, Zaiming Lu

    期刊:CHEMICO-BIOLOGICAL INTERACTIONS

    DOI:10.1016/j.cbi.2023.110343

    影响因子 :5.100

    引用产品:CL-0103 CL-0212

  • Daphnetin inhibits the survival of hepatocellular carcinoma cells through regulating Wnt/β-catenin signaling pathway(2022/02/07)

    作者:Chaohui Liu, Jiansheng Pan, Hongyu Liu

    期刊:Drug Development Research

    DOI:10.1002/ddr.21920

    影响因子 :5.004

    引用产品:CL-0120 CL-0212

  • Improving the antitumor efficiency against hepatocellular carcinoma by harmine-loaded liposomes with mitochondria targeting and legumain response(2022/08/01)

    作者:Ipargul Hafiz, Zhezhe Li, Zhaozhi Wang

    期刊:JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

    DOI:10.1016/j.jddst.2022.103623

    影响因子 :5.000

    引用产品:CL-0212

  • Pan-cancer analysis of 60S Ribosomal Protein L7-Like 1 (RPL7L1) and validation in liver hepatocellular carcinoma(2023/12/01)

    作者:Kejie He, Guoyu Gong, E Liang

    期刊:Translational Oncology

    DOI:10.1016/j.tranon.2023.101844

    影响因子 :5.000

    引用产品:CL-0212

  • Tumor purity–associated genes influence hepatocellular carcinoma prognosis and tumor microenvironment(2023/06/26)

    作者:Yan Zhao, Xu Xu, Yue Wang

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2023.1197898

    影响因子 :4.700

    引用产品:CL-0103 CL-0212 CL-0560 CL-0811

  • System analysis based on the lysosome-related genes identifies HPS4 as a novel therapy target for liver hepatocellular carcinoma(2023/09/13)

    作者:Kejie He, Zhiqiang Nie

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2023.1221498

    影响因子 :4.700

    引用产品:CL-0120 CL-0212

  • Circ_0007429/miR-637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC(2023/03/15)

    作者:Lilan Fan, Panpan Xia, Jing Wang

    期刊:MOLECULAR CARCINOGENESIS

    DOI:10.1002/mc.23526

    影响因子 :4.600

    引用产品:CL-0102 CL-0103 CL-0120 CL-0212

  • Humanized disulfide-stabilized diabody against fibroblast growth factor-2 inhibits PD-L1 expression and epithelial-mesenchymal transition in hepatoma cells through STAT3(2023/07/25)

    作者:Huamin Sun, Xinran Song, Cunjie Li

    期刊:IUBMB LIFE

    DOI:10.1002/iub.2766

    影响因子 :4.600

    引用产品:CL-0103 CL-0212

  • LncRNA KCNQ1OT1 inhibits the radiosensitivity and promotes the tumorigenesis of hepatocellular carcinoma via the miR-146a-5p/ACER3 axis(2020/09/16)

    作者:Ganghua Yang, Lijing Zhou, Qinhong Xu

    期刊:Cell Cycle

    DOI:10.1080/15384101.2020.1809259

    影响因子 :4.300

    引用产品:CL-0102 CL-0119 CL-0212

  • Antipsychotic agent pimozide promotes reversible proliferative suppression by inducing cellular quiescence in liver cancer(2019/07/11)

    作者:Jiajie Chen, Lina Zhang, Nan Cai

    期刊:Oncology Reports

    DOI:10.3892/or.2019.7229

    影响因子 :4.200

    引用产品:CL-0212

  • PAQR4 promotes the development of hepatocellular carcinoma by activating PI3K/AKT pathway(2021/10/30)

    作者:Gang Zhao, Xiaobao Shi, Zhanbo Sun

    期刊:Acta Biochimica Et Biophysica Sinica

    DOI:10.1093/abbs/gmab143

    影响因子 :3.511

    引用产品:CL-0120 CL-0212 CL-0415

  • Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis(202/3/12)

    作者:Huaqiang Bi, Zhonghui Li, Hui Zhang

    期刊:Hepatobiliary & Pancreatic Diseases International

    DOI:10.1016/j.hbpd.2020.02.011.

    影响因子 :3.300

    引用产品:CL-0119 CL-0120 CL-0212

  • Lysine demethylase 5C epigenetically reduces transcription of ITIH1 that results in augmented progression of liver hepatocellular carcinoma(2022/01/25)

    作者:Xu Qian, Zhongming Bao, Dan Yao

    期刊:Kaohsiung Journal of Medical Sciences

    DOI:10.1002/kjm2.12501

    影响因子 :3.300

    引用产品:164210 164210-50 CL-0120 CL-0212 PB180120

  • Identify GADD45G as a potential target of 4-methoxydalbergione in treatment of liver cancer: bioinformatics analysis and in vivo experiment(2023/10/13)

    作者:Liping Zeng, Yuqi Qin, Xiaomin Lu

    期刊:World Journal of Surgical Oncology

    DOI:10.1186/s12957-023-03214-3

    影响因子 :3.200

    引用产品:CL-0212

  • ZNF131 facilitates the growth of hepatocellular carcinoma by acting as a transcriptional activator of SMC4 expression(2024/01/11)

    作者:Meng Jin, Yang Mi, Fazhan Li

    期刊:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

    DOI:10.1016/j.bbrc.2024.149515

    影响因子 :3.100

    引用产品:CL-0212

  • NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma(2023/01/21)

    作者:Zigang Li, Chengshan You, Jun Huang

    期刊:MEDICAL SCIENCE MONITOR

    DOI:10.12659/MSM.938410

    影响因子 :3.100

    引用产品:CL-0102 CL-0212

  • Prognostic and Immune Infiltration Analysis of Transaldolase 1 (TALDO1) in Hepatocellular Carcinoma(2023/12/31)

    作者:Kedan Cen, Caide Lu

    期刊:International Journal of General Medicine

    DOI:10.2147/IJGM.S425490

    影响因子 :2.300

    引用产品:CL-0212

  • Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of Υ-synuclein in hepatocellular carcinoma cells(2016/12/27)

    作者:Xiaoqin He, Yongfa Zheng, Yuefeng Zhang

    期刊:Oncotarget

    DOI:10.18632/oncotarget.14276

    影响因子 :0.000

    引用产品:CL-0103 CL-0212

  • 点击展开收起列表
丁莎/胡文君

丁莎/胡文君

【 上海 】

凌晶

凌晶

【 陕西 】

朱莎莉

朱莎莉

【 湖北、河南 】

刘本佳

刘本佳

【 江苏、安徽 】

章臣雄

章臣雄

【 广东、云南 】

閤春喜

閤春喜

【 四川、甘肃、西藏 】

田博浩

田博浩

【 重庆、吉林 】

石文平

石文平

【 北京、黑龙江、辽宁 】

任施博

任施博

【 江西、福建、新疆、海南 】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 湖南、山东、宁夏、青海 】

尹国文

尹国文

【浙江、广西、贵州】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询
联系销售

关注微信公众号